Raymond Prudo Chlebosz is of Akari Therapeutics Plc. Currently has a direct ownership of 4.08 Billion shares of AKTX, which is worth approximately $4.08 Billion. The most recent transaction as insider was on Dec 02, 2024, when has been sold 419,286,000 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.08B
11.46% 3M change
n/a 12M change
Total Value Held $4.08 Billion

Raymond Prudo-Chlebosz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2024
BUY
Grant, award, or other acquisition
-
419,286,000 Added 9.32%
4,077,124,600 Ordinary shares, par v...
May 31 2024
BUY
Grant, award, or other acquisition
-
0 Added 0.0%
3,657,838,600 Ordinary shares, par v...
RP

Raymond Prudo Chlebosz

Boston, MA

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Track Activities on AKTX